Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
China Sends Mixed Signals for Healthcare as Outlook Shift from Cautious Optimism...
Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on mixed signals for Chinese pharma recently, as well as dev... (3/1/2019)
   
Shine News: MAH Program A Shot in the Arm for Chinese Pharmaceutical Industry (3/19/2019)
5 Key Elements of Chinese Biopharma's "Cambrian Explosion" (3/17/2019)
A Merck Cancer Treatment Has a Big Opportunity in China, Analyst Says (3/13/2019)
China Sends Mixed Signals for Healthcare as Outlook Shift from Cautious Optimism to Cautious Pessimism for Many (3/1/2019)
New IFPMA Code of Practice Tightens Restrictions on Gifts (with Case on RDPAC Code Changes) (2/27/2019)
Chinese Biotech Feels Chill in Harsh Winter for Venture Capital (2/26/2019)
More Changes Possible in China's Patent Law Amendment? (2/21/2019)
Whatever The Outcome Of U.S.-China Trade Talks, Global Supply Chains Are Set To Change (2/21/2019)
PharmExec - Mixed Outlook for China Life Sciences (2/16/2019)
PharmExec - China: A Change in Attitude (2/16/2019)
PharmExec - New Roads to China (2/16/2019)
China's Biotechnology Development: The Role of U.S. and Other Foreign Engagement (2/14/2019)
Review of Chinese Pharma Deals, R&D and Regulatory Developments in 2018 (2/13/2019)
Chinese Pharma under Cloud Again in the Supposedly Lucky Year of the Pig (2/12/2019)
SAMR Fines Hunan Er-Kang And Henan Jiushi CNY 10M for Unfair Pricing Of Chlorpheniramine API (2/8/2019)
CanSinoBio to Launch $161M Hong Kong IPO...  (3/19/2019)
MilliporeSigma to Collaborate with GenSc...  (3/19/2019)
ImmunoBiology and CNBG Enter Licensing P...  (3/19/2019)
Korean Pharma Il-yang and Hanmi Report R...  (3/19/2019)
Takeda to Invest CNY 110M into Expanding...  (3/19/2019)
Merck KGaA Aims to Double China Sales by...  (3/19/2019)
Xynomic Pharma Gains Phase III Trial App...  (3/17/2019)
NHSA Releases 2018 Healthcare Security S...  (3/15/2019)
Upcoming Event: 4th Asean Pharma Packagi...  (3/15/2019) (free)
Upcoming Event: Precision Medicine Congr...  (3/15/2019) (free)
Recent Executive Moves  (3/15/2019)
Upcoming Event: 3rd Publishers Summit  (3/15/2019) (free)
Upcoming Event: 3rd edition of the Shang...  (3/15/2019) (free)
Astellas Launches Teijin’s Gout Medicin...  (3/15/2019)
Pharma China Annual Forum 2019 (April 9,...  (3/15/2019) (free)
IQVIA: Global Pharma to Grow Slower in the Next Five Yea...
Pfizer and GSK Announce JV to Create a Global Consumer H...
Top 25 Global Pharmaceutical Companies by Market Cap 201...
CANbridge Receives IND Approval to Commence CAN008 Phase...
Global Contract Pharmaceutical Manufacturing Market to R...
Chinese Diabetes Drug Market Continues to be Dominated by MNCs ...
IQVIA/McKinsey: Generics Continue to Dominate Chinese Pharma Ma...
IQVIA Publishes Report on Orphan Drug Access in China as the Co...
Sinohealth: Chinese Retail Pharmacy Sales Slowed to the Lowest ...
Nicholas Hall Reports 6% Growth for Chinese OTC VMS Market in 2...
CanSinoBio to Launch $161M Hong Kong IPO
MilliporeSigma to Collaborate with GenScript to Accelerate C...
ImmunoBiology and CNBG Enter Licensing Pact to Co-Develop Va...
Korean Pharma Il-yang and Hanmi Report Robust Sales Growth i...
Takeda to Invest CNY 110M into Expanding Its Chinese Manufac...
CDE Solicits Public Comments on Clinical Trial Guideline...
Chongqing Approved to Set Up Destination Port for First-...
CDE Seeks Comments on Draft ICH Guideline M8 and E2F
Chinese Generic Drug Applications Rebound in 2018 After ...
CDE Publicizes 8+3 More Drug Applications To Be Granted ...
USTR's 2018 Report for China's WTO Compliance Highlight IP I...
Report: China Tightens IP Protection and Expands Patent Refo...
China Claims Steady Progress in Key Indicators of IP in 2018...
China: Gene-Editing Scientist Broke Laws for ‘Personal Fame...
Hogan Lovells: Pharma Companies May Benefit from Proposed Pa...
Huahai Pharma Involved In Another Blood Pressure Drug Re...
Novo Nordisk Pharmatech A/S signs Asia Pacific distribut...
Trade Bodies Warns API Supply Chain Disruptions from Chi...
India Seeks to Reduce Reliance on Chinese Pharma Imports...
USFDA Warns Zhejiang Huahai for Failure to Detect Valsar...
CASI Pharma Announces CTA Approval for MARQIBO
Novartis Reports Positive Data from Chinese Trial of Cos...
Novartis Submits NDA of Latest MS Drug Siponimod in Chin...
CASI Pharma Granted CTA To Conduct Clinical Trial of ZEV...
Hua Medicine Initiates First Combination Study of Dorzag...
NHSA Releases 2018 Healthcare Security Sector Developmen...
China Faces A Daunting Healthcare Bill from Heart Diseas...
Chinese Experts Warn of Rising Kidney Disease in the Cou...
NHSA Issues Action Plan for 2019 NRDL Revision
Large Scale/Long Term Study Confirms Correlation Between...
Recent Executive Moves
42 Chinese Pharma Billionaires Made the Hurun Global Rich ...
Recent Executive Moves
Recent Official and Executive Moves
Recent Executive Moves
Upcoming Event: 4th Asean Pharma Packaging Conference
Upcoming Event: Precision Medicine Congress
Upcoming Event: 3rd Publishers Summit
Upcoming Event: 3rd edition of the Shanghai eHealth Work...
Pharma China Annual Forum 2019 (April 9, Shanghai)
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON to Hold Pharma China Ann...
  WiCON Publishes the China Phar...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links